Neogen (NEOG) Stock News

Neogen (NEOG) shares fell after the company reported a Q1 beat-and-raise. The headline growth included roughly 300-400 basis points from order timing and easier comparisons. The FY27 guidance increase was modest: revenue midpoint up $5 million, EBITDA midpoint up $1 million. Management expects Q2 to be the low point for growth this fiscal year. The stock had hit a 52-week high in late September, which may have encouraged profit-taking.

Neogen beat Q1 estimates and raised guidance, but Guggenheim noted about 3 percentage points of core growth came from one-time factors. Management sees first-half core growth slowing to roughly 3.5%. Shares fell 2.4%.

Neogen lifts FY27 revenue and adjusted EBITDA guidance.

Revenue $222.8M, up 6.5%; core growth 8.1%. Net loss $11.9M (prior year net income $36.3M on divestiture gain). Adjusted EPS $0.08 vs $0.04. Adjusted EBITDA margin 18.7% vs 17.0%. Raised FY27 revenue and adjusted EBITDA guidance. Petrifilm transition on track for November.

Neogen fiscal Q1 adjusted EPS 8 cents.

Neogen (NEOG) announced a strategic collaboration and equity investment in Hinalea Imaging to develop hyperspectral imaging solutions for food safety and quality inspection. The companies have worked together since 2025 and plan to jointly develop solutions to automate inspection workflows.